InMed Pharmaceuticals (INM) Current Assets (2021 - 2025)
Historic Current Assets for InMed Pharmaceuticals (INM) over the last 5 years, with Q4 2025 value amounting to $8.8 million.
- InMed Pharmaceuticals' Current Assets rose 6066.66% to $8.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $8.8 million, marking a year-over-year increase of 6066.66%. This contributed to the annual value of $12.9 million for FY2025, which is 4807.7% up from last year.
- Per InMed Pharmaceuticals' latest filing, its Current Assets stood at $8.8 million for Q4 2025, which was up 6066.66% from $10.8 million recorded in Q3 2025.
- InMed Pharmaceuticals' 5-year Current Assets high stood at $16.0 million for Q3 2021, and its period low was $5.5 million during Q4 2024.
- In the last 5 years, InMed Pharmaceuticals' Current Assets had a median value of $10.4 million in 2024 and averaged $10.3 million.
- As far as peak fluctuations go, InMed Pharmaceuticals' Current Assets tumbled by 5368.26% in 2024, and later soared by 6066.66% in 2025.
- Over the past 5 years, InMed Pharmaceuticals' Current Assets (Quarter) stood at $12.5 million in 2021, then rose by 12.1% to $14.0 million in 2022, then decreased by 15.75% to $11.8 million in 2023, then plummeted by 53.68% to $5.5 million in 2024, then surged by 60.67% to $8.8 million in 2025.
- Its Current Assets stands at $8.8 million for Q4 2025, versus $10.8 million for Q3 2025 and $12.9 million for Q2 2025.